This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on July 31, 2020. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

REQUEST FOR QUOTE-A1435101 EXPI293 EXPRESSION MEDIUM/12338018 FREESTYLE 293 EXPRESSION MED

Closed

RFQ-NIH-2029193Federal

Submission Closed08/14/2020, 01:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325413

New

DIBBS

TEST KIT, CHLAMYDIA TRA

Solicitation # SPE2DS-26-T-281C

This contract is for the procurement of a qualitative direct immunofluorescence test kit designed for the detection of Chlamydia trachomatis in human urogenital and ocular specimens, as well as for confirming Chlamydiae in cell culture. The kit includes two positive control slides, mounting fluid, and the Chlamydia test reagent, ensuring reliable and standardized diagnostic capability. The item is identified by NSN/Part Number 6550-01-725-3600, with a single kit ordered under Purchase Request 7017651737. Delivery is expected within 20 days after order. The solicitation, numbered SPE2DS-26-T-281C, was posted on July 28, 2026, with responses due by August 3, 2026, under a federal procurement process managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office. The place of performance is listed as APO with ZIP code 09094-3219, indicating military or overseas delivery. The primary point of contact is Mary-Kathryn Donahue, reachable via email and phone for inquiries. The NAICS code 325413 classifies this as a pharmaceutical and medicine manufacturing activity, affirming the technical and regulatory standards applicable to the test kit's production and distribution.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, BACTERIA DETE

Solicitation # SPE2DS-26-T-278C

The test kit is a single-use, self-contained system designed for the rapid detection of coliforms, E. coli, and hydrogen sulfide-producing Enterobacteriaceae such as Salmonella and Citrobacter in food, beverages, and water samples. It incorporates a specialized gelling agent that enables both presence/absence testing and quantification of colony forming units with a sensitivity of 1 CFU per 100 mL in water and 1 CFU per 3 mL in juice, delivering results within 28 hours. The unit of issue is PG, with 25 kits per package, and it is identified by NSN 6550-01-723-3649. The product must comply with mandatory technical and quality requirements referenced in the DLA Master List and adhere to medical packaging standards, specifically Medical Marking Standard No. 1, which replaces MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe delivery via common carrier at the lowest cost to the specified delivery point at Fort Bragg, NC. The item has a non-extendable shelf life of six months, with no more than one month elapsed between manufacture and government delivery. Storage and shipping must occur at 15 to 25 degrees Celsius, and all labels must include the manufacture date, expiration date, retest date, contract number, and lot number, formatted per the latest MMS1C guidelines. Bidders are required to specify the source and part number being offered, and the solicitation under contract number SPE2DS-26-T-278C closes on August 3, 2026, with delivery expected within 20 days after award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-282G

The CONTROL LOOP SET is a microbiological control culture item specifically designed for Streptococcus pyogenes ATCC 19615, intended for use in laboratory quality control procedures. It requires refrigerated storage between 2 to 8 degrees Celsius and must not be frozen. Each package contains five units, designated as one PG (package), and must be packaged and marked in strict compliance with Medical Marking Standard No. 1, replacing all references to MIL-STD-129. The item has a non-extendable shelf life of 15 months, with no more than two months allowed to have passed from the date of manufacture to the date of delivery to the government. All labels must clearly display the date of manufacture, expiration or retest date, and the contract or lot number, following the latest revision of MMS1C. This item is subject to DLA packaging and labeling requirements, and all supplies must be properly sealed and packed in commercial-grade containers suitable for safe transport by common carriers at the lowest cost to the designated delivery point, which is APO 09094-3219. The procurement is governed by technical and quality requirements identified in the DLA Master List and is classified as a TYPE I (CODE J) item under shelf-life regulation RS012. The National Stock Number is 6550-01-691-8597, with a single package ordered under purchase request 7017651773, and delivery is required within five days of award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-280F

The contract is for the procurement of 5 cases of Abbott BinaxNOW COVID-19 Antigen Self Tests, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2°C and 30°C and must have a shelf life of exactly 12 months with no extensions permitted, and no more than one month may have passed from the date of manufacture to the date of delivery to the government. All units must be packaged commercially in sealed containers that protect against damage, with exterior shipping containers suitable for safe, cost-effective delivery via common carriers. Labeling must comply with Medical Marking Standard No. 1, including the date of manufacture, expiration date, contract number, and lot number, and all government identification must be removed from non-accepted supplies. Technical and quality requirements referenced in the DLA Master List of Technical and Quality Requirements are incorporated by inclusion, and the items are subject to the DLA packaging standards and marking specifications. The contract is tied to NSN 6550-01-716-1573, with a delivery requirement within 20 days after order, and falls under the solicitation SPE2DS-26-T-280F issued by the Department of Defense, with primary point of contact at DLA Troop Support.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Illumina Respiratory Virus Enrichment Kit, MiSeq Reagent Nano Kit, and PhiX Control

Solicitation # N6311626Q0555

The Naval Health Research Center in San Diego, California, intends to award a sole-source contract to ILLUMINA, INC. under the statutory authority of 10 U.S.C. 3204(a)(1), which permits procurement from only one responsible source. The contract is for the supply of specific laboratory reagents and kits including the Illumina Respiratory Virus Enrichment Kit Set A with 96 indexes and 96 samples, the MiSeq Reagent Nano Kit v2 (300-cycles), and the PhiX Control v3. These materials are essential for respiratory virus research and genomic sequencing activities conducted at the center. Although this is a notice of intent and not a formal request for proposals, the government will consider any responses from responsible sources that submit timely and complete information. All potential responders must be registered in SAM.gov and have completed all required FAR and DFARS representations and certifications. Deliveries are scheduled to occur between September 2, 2026, and March 2, 2027. Submissions must reference solicitation number N6311626Q0555 and include the company name, full address, CAGE code, and detailed point of contact information consisting of name, phone number, and email address. The primary point of contact for this procurement is David L. Hill, and the place of performance is in San Diego, California. Responses are due by August 5, 2026, and all submissions must adhere to the specified format and documentation requirements to be considered.

Naval Health Research Center

POSTED

DEADLINE

GLA VA - 10X Genomics Visium HD kit - Genomics Reagents

Solicitation # 36C26226Q1264

The Department of Veterans Affairs is seeking a qualified small business vendor to supply a 10X Genomics Visium HD kit for spatial single-cell RNA sequencing in support of Dr. Philip Scumpia’s research. The solicitation, identified as 36C26226Q1264, is a small business set-aside under NAICS code 325413 for genomics reagents, with a response deadline of August 18, 2026. The required products include the Visium HD Mouse Transcriptome kit with 8 reactions and the Visium CytAssist Alignment Aid Kit, both of which must be U.S.-made or from designated country end products under federal trade agreements. Proposals must include a formal quote, a letter of authorization from the manufacturer, and full vendor details including business size, socioeconomic classification, UEI number, and confirmation of authorized distributor status if applicable. The contract is being managed by the VA office in Long Beach, California, with performance to occur in Los Angeles, and all inquiries should be directed to Sabrina Schofield.

262F Nco 22 Nonary VA Care (00262F)

POSTED

DEADLINE

TEST KIT, E COLI DETECT

Solicitation # SPE2DS-26-T-276M

The contract is for the procurement of Colilert-18 test kits designed to detect both total coliforms and Escherichia coli in water or fecal coliforms in wastewater, with results available within 18 hours. The kits must be stored between 2 and 25 degrees Celsius and protected from light. The product is regulated by the FDA, requiring a referral to a product specialist for confirmation prior to award. The items must be supplied with an identified source and part number, specifically IDEXX DISTRIBUTION INC P/N 98-00876-00 or IDEXX LABORATORIES INC P/N 98-08876-00, and must comply with all applicable technical and quality requirements referenced in the DLA Master List. A shelf life of 15 months, non-extendable, is mandated under RS001 for TYPE I (CODE J) items. Packaging and labeling must adhere to the Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in a protective container and packed in commercial shipping containers suitable for safe transit at the lowest possible rate. The unit of issue is PG, with a total quantity of 3 packs required. Delivery is FOB destination within 20 days, with zero variance allowed in quantity. The delivery address is Peterson Air Force Base, Colorado, and shipping must be conducted via traceable means, explicitly excluding parcel post. All packaging and marking must comply with the latest version of the DLA Medical Marking Standard, and the contract is subject to Defense Federal Acquisition Regulation Supplement requirements including potential handling of covered defense information. The solicitation number is SPE2DS-26-T-276M with a response deadline of August 3, 2026, and the original required delivery date is July 29, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Combined Synopsis Solicitation- Acquire 32-sample

Solicitation # 75N98026Q00881

The National Institutes of Health, through the Department of Health and Human Services, is soliciting proposals under a non-competitive combined synopsis and solicitation for the acquisition of a 32-sample product, identified by solicitation number 75N98026Q00881. This procurement is conducted under FAR Part 12.603 as a streamlined process for commercial items and falls below the simplified acquisition threshold, utilizing statutory authority under 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii) to justify the absence of full and open competition. The solicitation is issued as a Notice of Intent and serves as the only formal request for proposals, with no additional written solicitation to follow. Proposals must be submitted by the deadline of August 3, 2026, at 6:00 p.m. Eastern Time, following the posting date of July 27, 2026. The contracting activity is managed by the Office of Acquisition and Logistics Operations in Bethesda, Maryland, with the NAICS code 325413 indicating the product relates to pharmaceutical and medicine manufacturing. The primary point of contact for inquiries is Cassie M. Runner, reachable via email at cassie.runner@nih.gov or phone at 301-480-8827. The place of performance has not been specified, but the contract award will be directed toward a commercial supplier capable of meeting requirements without competitive bidding, in alignment with the streamlined procedures and statutory exceptions under federal acquisition regulations. All responses must comply with the terms outlined in the combined synopsis, and no further documentation will be issued beyond this notice.

National Institutes Of Health Olao

POSTED

DEADLINE

TEST KIT, CORONAVIRUS D

Solicitation # SPE2DS-26-T-269U

The contract specifies the procurement of 3 cases of Abbott BinaxNOW COVID-19 Antigen Self Test kits, each case containing 12 kits with two tests per kit, for at-home, over-the-counter use. Each test kit must be stored between 2 and 30 degrees Celsius and is subject to a strict 12-month shelf life with no extensions permitted; no more than one month may have passed from the date of manufacture to the date of delivery to the government. All kits must be labeled with the date of manufacture, expiration or retest date, and the contract and lot numbers in compliance with Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, ensuring protection from damage and safe delivery via common carrier to the designated delivery point in FPO, 96674, while minimizing shipping costs. The item is identified by NSN 6550-01-716-1573 under solicitation SPE2DS-26-T-269U, with a 20-day delivery requirement and a response deadline of August 3, 2026. Technical and quality requirements referenced by R or I numbers are governed by the DLA Master List, and the procurement is subject to covered defense information protocols and DLA packaging standards.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Solicitation # SPE2DS-26-T-270X

The contract is for a CONTROL LOOP SET, specifically designed for microbiology use with Streptococcus pyogenes ATCC 19615, requiring refrigerated storage between 2°C and 8°C (36°F to 46°F) and prohibiting freezing. Each package contains five units, sold as a single purchasing unit (PG), and the item carries a non-extendable shelf life of 15 months, with no more than two months allowed to have elapsed from the date of manufacture to delivery. All labeling must comply with MMS1C, including explicit markings for the date of manufacture, expiration or retest date, and the contract or lot number. Packaging guidelines follow commercial standards and the Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical acquisitions; exterior shipping containers must ensure safe delivery at the lowest freight rate using traceable carriers, with parcel post strictly prohibited. The item is governed by a suite of DFARS and FAR clauses, including requirements for safeguarding covered defense information, cyber incident reporting, NIST SP 800-171 compliance, and restrictions on covered telecommunications equipment. Transportation must comply with maritime regulations favoring U.S.-flag vessels. Quality and technical specifications are derived from the DLA Master List of Technical and Quality Requirements, and packaging must meet RP001 DLA standards, including proper preservation per MIL-STD-2073-1E to maintain product integrity. The item is subject to destination inspection under FAR 52.246-2, with acceptance performed by the Government. The solicitation, issued under number SPE2DS-26-T-270X, has a response deadline of August 3, 2026, and requires electronic submission via DIBBS. The delivery point is identified as a Department of Defense address in Hampton, Virginia, with an overall delivery window of 20 days after the actual delivery order. Pricing varies by quantity, with extended contract values reaching up to $11,853.76 based on multiple line items. Contractors must have an active UEI and CAGE code, represent their size and socioeconomic status accurately, and comply with anti-trafficking, employment eligibility, and sustainable product requirements. All payment submissions must be processed through WAWF, and the contract prohibits the use of mandatory arbitration agreements and restricts compensation for former DoD officials.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Roche Flu Surveillance Testing ReagentThe contract anticipates the procurement of testing reagents for influenza surveillance under the Forensic Sciences Division of the District of Columbia for fiscal year 2026. The initiative is part of a broader public health effort to monitor flu activity, with reagents intended for use in diagnostic and surveillance testing. While specific quantities, delivery timelines, or technical specifications are not detailed in the forecast, the reagents will support laboratory-based detection and analysis of influenza strains across the jurisdiction. This procurement is categorized as a forecast, indicating it is a planning tool for vendors to prepare for an upcoming solicitation, and no formal solicitation number has been issued as of the posting date. The agency responsible, DFS, is based in Washington D.C., and performance is expected to occur within the district, though no specific location is provided. Vendors interested in participating should monitor future official solicitations, as this forecast serves only as an early indicator of intent and does not constitute a binding request for proposals.

Forensic Sciences (DFS)

POSTED

DEADLINE

FY26 FR0 DFS/PHL - Cepheid Norovirus, Mpox, Multiplex ReagentThe contract pertains to the acquisition of testing supplies specifically for the Cepheid Norovirus, Mpox, and Multiplex reagents under the Fiscal Year 2026 forecast for the Department of Forensic Sciences in the District of Columbia. It is categorized as a forecast listing, indicating it is a planned procurement rather than an active solicitation, with no formal solicitation number assigned at this time. The primary focus is on reagents used in diagnostic testing to support forensic and public health laboratories, likely to enhance detection capabilities for infectious agents relevant to criminal investigations and community health monitoring. There is no designated set-aside type, NAICS code, or organizational type specified, and the agency details are limited to the Forensic Sciences division within the District of Columbia, with no明确 office address or place of performance provided. No point of contact information is listed, and the contract remains in a pre-solicitation phase, intended to inform potential vendors of upcoming procurement needs. The associated UI link provides access to the official forecast posting for further details as the procurement process advances.

Forensic Sciences (DFS)

POSTED

6 days ago

DEADLINE

N/A

General Info

Agency

Department Of Health And Human Services → NIH National Institute Of Allergy And Infectious DiseasesView Agency

NAICS

325413 - In-Vitro Diagnostic Substance ManufacturingView NAICS

Place of Performance

Bethesda, MD, 20892, USA

Set-Aside

NONE

Documents

(2)

52.212-5+JULY+2020-CLAUSE.pdf

PDF

ATTACHMENT+FOR+POSTING+JOFOC.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedJul 31

Presolicitation

Response DeadlineAug 14

Deadline has passed

Submission Closed

08/14/2020, 01:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Health And Human Services → NIH National Institute Of Allergy And Infectious Diseases

Contacts2 people available

OfficeBethesda, MD, 20892, USA

Organization / Agency

Department Of Health And Human Services → NIH National Institute Of Allergy And Infectious Diseases

View Agency Profile

Office AddressBethesda, MD, 20892, USA

Contacts

Lorena Waller

Skye Duffner

Full Description

This notice is a combined synopsis/solicitation for commercial items using Simplified Acquisition Procedures. This acquisition will be made in accordance with the format in Federal Acquisition Regulation (FAR) Subpart 12.6 - Streamlined Procedures for Evaluation and solicitation for commercial Items, as applicable, and as supplemented with additional information included in this notice. This announcement constitutes the only solicitation (a written solicitation will not be issued) and quotes are being requested. The Solicitation number is RFQ-NIH-2029193 and the solicitation is issued as a Request for Quotes (RFQ). This acquisition will be processed under FAR Part 13 Simplified Acquisition Procedures (SAP). The solicitation documents and incorporated provisions and clauses are those in effect through Federal Acquisition Circular (FAC) 2020-07 July 02, 2020. The North American Industry Classification System (NAICS) code for this procurement is 325413, In Vitro Diagnostic Substance Manufacturing. The requirement is being competed with a brand name restriction, and without a small business set-aside. The National Institute of Allergy and Infectious Diseases (NIAID) has a requirement for: A1435101 EXPI293 EXPRESSION MEDIUM 1000 ML-qty 300 12338018 FREESTYLE 293 EXPRESSION MED 1000ML-qty 300 Place of Performance: NIH, 9000 Rockville Pike, BLDG 40, Bethesda, MD 20892, United States. FOB: Destination The government intends to award a firm fixed price purchase order to the responsible contractor as a result of this RFQ that will include the terms and conditions set forth herein. The award will be based on the following; technical capability to meet the requirements and price. The following FAR provisions apply to this acquisition: FAR 52.212-1 Instructions to Offerors Commercial Items (June 2020) FAR 52.212-3 Offerors Representations and Certifications - Commercial Items (June 2020) FAR 52.204-7 System for Award Management (Oct 2018) (Offerors must complete annual representations and certifications on-line at http://www.sam.gov/ in accordance with FAR 52.212-3 Offerors Representations and Certifications- Commercial Items (Please ensure 52.209-2 -- Prohibition on Contracting with Inverted Domestic Corporations--Representation. (Nov 2015) is updated in your SAM record) FAR 52.203-18 Prohibition on Contracting with Entities that Require Certain Internal Confidentiality Agreements - Representation (Jan 2017) 52.204'24 Representation Regarding Certain Telecommunications and Video Surveillance Services or Equipment (Dec 2019) *** Must complete representation if attached to this solicitation- see attachment 52.204-24 The following FAR contract clauses apply to this acquisition: FAR 52-212-4 Contract Terms and Conditions Commercial Items (October 2018) FAR 52-212.5 Contract Terms and Conditions Required to Implement Statutes or Executive Orders Commercial Items (July 2020) *The applicable subparagraphs of FAR52.212-5 are included in the attachment to this posting. FAR 52.232-40 Providing Accelerated Payments to Small Business Subcontractors (Dec 2013) FAR 52.204-13 System for Award Management Maintenance (Oct 2018) HHSAR 352.222-70, Contractor Cooperation in Equal Employment Opportunity Investigations (December 2015) 52.252-2 -- Clauses Incorporated by Reference. (Feb 1998) This contract incorporates one or more clauses by reference, with the same force and effect as if they were given in full text. Upon request, the Contracting Officer will make their full text available. Also, the full text of a clause may be accessed electronically at this address: www.acquisition.gov By submission of an offer, the offeror acknowledges the requirement that a prospective awardee shall be registered in the System for Award Management (SAM) database prior to award, during performance, and through final payment of any contract, basic agreement, basic ordering agreement, or blanket purchasing agreement resulting from this solicitation (www.sam.gov). Copies of the above-referenced provisions and clauses are available from http://www.acquisition.gov/far/loadmainre.html & http: //www.hhs.gov/regulation/index.html or, upon request, either by telephone or fax. Submission shall be received not later than August 14th, 2020 @ 9:00 amEST Offers may be mailed, e-mailed to Lorena Waller), (E-Mail/ Wallerlor@niaid.nih.gov). Offers shall include RFQ number in the subject line (RFQ-NIH-2029193). Late submissions shall be treated in accordance with the solicitation provision at FAR 52.212-1(f) All responsible sources may submit an offer that will be considered by this Agency. Any questions or concerns regarding this solicitation should be forwarded in writing via email to Wallerlor@niaid.nih.gov.